Validation of the Chinese Version of the 16-Item Negative Symptom Assessment

Bing-jie Huang,1– 4 Yong Wang,1– 4 Qi Miao,1– 4 Xin Yu,1– 4 Cheng-cheng Pu,1– 4 Chuan Shi1– 4 1Clinical Research Department, Peking University Sixth Hospital, Beijing, People’s Republic of China; 2Institute of Mental Health, Pekin...

Full description

Bibliographic Details
Main Authors: Huang B, Wang Y, Miao Q, Yu X, Pu C, Shi C
Format: Article
Language:English
Published: Dove Medical Press 2020-05-01
Series:Neuropsychiatric Disease and Treatment
Subjects:
nsa
Online Access:https://www.dovepress.com/validation-of-the-chinese-version-of-the-16-item-negative-symptom-asse-peer-reviewed-article-NDT
id doaj-40a0834ac7c944cc891dcf7f9cff897a
record_format Article
spelling doaj-40a0834ac7c944cc891dcf7f9cff897a2020-11-25T02:54:06ZengDove Medical PressNeuropsychiatric Disease and Treatment1178-20212020-05-01Volume 161113112053503Validation of the Chinese Version of the 16-Item Negative Symptom AssessmentHuang BWang YMiao QYu XPu CShi CBing-jie Huang,1– 4 Yong Wang,1– 4 Qi Miao,1– 4 Xin Yu,1– 4 Cheng-cheng Pu,1– 4 Chuan Shi1– 4 1Clinical Research Department, Peking University Sixth Hospital, Beijing, People’s Republic of China; 2Institute of Mental Health, Peking University, Beijing, People’s Republic of China; 3NHC Key Laboratory of Mental Health (Peking University), , Beijing, People’s Republic of China; 4National Clinical Research Center for Mental Disorders (Peking University Sixth Hospital), Beijing, People’s Republic of ChinaCorrespondence: Cheng-cheng Pu; Chuan Shi Email pciami@163.com; shichuan@bjmu.edu.cnPurpose: The Negative Symptom Assessment-16 (NSA-16) is an instrument with significant validity and utility for assessing negative symptoms associated with schizophrenia. This study aimed to validate the Chinese version of the NSA-16.Patients and Methods: A total of 172 participants with schizophrenia were assessed with the NSA-16, Scale for Assessment of Negative Symptoms (SANS), Positive and Negative Syndrome Scale (PANSS), Calgary Depression Scale for Schizophrenia (CDSS) and Rating Scale for Extrapyramidal Side Effects (RSESE). The factor structure of the NSA-16 was evaluated via exploratory and confirmatory factor analysis. Cronbach’s α and intraclass correlation coefficients were computed. Correlations were evaluated via Spearman correlation coefficient.Results: The original five-factor model of the NSA-16 did not fit our sample. Exploratory factor analysis followed by confirmatory factor analysis suggested a three-factor structure, consisting of communication, emotion and motivation, with 15 items. The NSA with 15 items was termed as the NSA-15. The NSA-15 showed excellent convergent validity by high correlations with the SANS and PANSS total and negative factor scores and good divergent validity by independence from the PANSS positive factor, CDSS and RSESE. The NSA-15 showed good internal consistency, interrater reliability and test–retest reliability.Conclusion: The NSA-15 is best characterized by a three-factor structure and is valid for assessing negative symptoms of schizophrenia in Chinese individuals.Keywords: negative symptoms, schizophrenia, NSA, reliability, validityhttps://www.dovepress.com/validation-of-the-chinese-version-of-the-16-item-negative-symptom-asse-peer-reviewed-article-NDTnegative symptomsschizophreniansareliabilityvalidity
collection DOAJ
language English
format Article
sources DOAJ
author Huang B
Wang Y
Miao Q
Yu X
Pu C
Shi C
spellingShingle Huang B
Wang Y
Miao Q
Yu X
Pu C
Shi C
Validation of the Chinese Version of the 16-Item Negative Symptom Assessment
Neuropsychiatric Disease and Treatment
negative symptoms
schizophrenia
nsa
reliability
validity
author_facet Huang B
Wang Y
Miao Q
Yu X
Pu C
Shi C
author_sort Huang B
title Validation of the Chinese Version of the 16-Item Negative Symptom Assessment
title_short Validation of the Chinese Version of the 16-Item Negative Symptom Assessment
title_full Validation of the Chinese Version of the 16-Item Negative Symptom Assessment
title_fullStr Validation of the Chinese Version of the 16-Item Negative Symptom Assessment
title_full_unstemmed Validation of the Chinese Version of the 16-Item Negative Symptom Assessment
title_sort validation of the chinese version of the 16-item negative symptom assessment
publisher Dove Medical Press
series Neuropsychiatric Disease and Treatment
issn 1178-2021
publishDate 2020-05-01
description Bing-jie Huang,1– 4 Yong Wang,1– 4 Qi Miao,1– 4 Xin Yu,1– 4 Cheng-cheng Pu,1– 4 Chuan Shi1– 4 1Clinical Research Department, Peking University Sixth Hospital, Beijing, People’s Republic of China; 2Institute of Mental Health, Peking University, Beijing, People’s Republic of China; 3NHC Key Laboratory of Mental Health (Peking University), , Beijing, People’s Republic of China; 4National Clinical Research Center for Mental Disorders (Peking University Sixth Hospital), Beijing, People’s Republic of ChinaCorrespondence: Cheng-cheng Pu; Chuan Shi Email pciami@163.com; shichuan@bjmu.edu.cnPurpose: The Negative Symptom Assessment-16 (NSA-16) is an instrument with significant validity and utility for assessing negative symptoms associated with schizophrenia. This study aimed to validate the Chinese version of the NSA-16.Patients and Methods: A total of 172 participants with schizophrenia were assessed with the NSA-16, Scale for Assessment of Negative Symptoms (SANS), Positive and Negative Syndrome Scale (PANSS), Calgary Depression Scale for Schizophrenia (CDSS) and Rating Scale for Extrapyramidal Side Effects (RSESE). The factor structure of the NSA-16 was evaluated via exploratory and confirmatory factor analysis. Cronbach’s α and intraclass correlation coefficients were computed. Correlations were evaluated via Spearman correlation coefficient.Results: The original five-factor model of the NSA-16 did not fit our sample. Exploratory factor analysis followed by confirmatory factor analysis suggested a three-factor structure, consisting of communication, emotion and motivation, with 15 items. The NSA with 15 items was termed as the NSA-15. The NSA-15 showed excellent convergent validity by high correlations with the SANS and PANSS total and negative factor scores and good divergent validity by independence from the PANSS positive factor, CDSS and RSESE. The NSA-15 showed good internal consistency, interrater reliability and test–retest reliability.Conclusion: The NSA-15 is best characterized by a three-factor structure and is valid for assessing negative symptoms of schizophrenia in Chinese individuals.Keywords: negative symptoms, schizophrenia, NSA, reliability, validity
topic negative symptoms
schizophrenia
nsa
reliability
validity
url https://www.dovepress.com/validation-of-the-chinese-version-of-the-16-item-negative-symptom-asse-peer-reviewed-article-NDT
work_keys_str_mv AT huangb validationofthechineseversionofthe16itemnegativesymptomassessment
AT wangy validationofthechineseversionofthe16itemnegativesymptomassessment
AT miaoq validationofthechineseversionofthe16itemnegativesymptomassessment
AT yux validationofthechineseversionofthe16itemnegativesymptomassessment
AT puc validationofthechineseversionofthe16itemnegativesymptomassessment
AT shic validationofthechineseversionofthe16itemnegativesymptomassessment
_version_ 1724722492785819648